HCV

April 4, 2017April 4, 2017

New Study Investigates Link Between Viral Hepatitis and Parkinson’s Disease

A new study reported that both hepatitis B and hepatitis C viral infections may be associated with an increased risk of developing Parkinson’s disease. The study was published in the journal Neurology, the ... Read more

March 28, 2017March 28, 2017

European Public Health Alliance Joins Patent Opposition for HCV Treatment

Hepatitis C, News

The European Public Health Alliance (EPHA) is one of 30 civil society organizations from 17 European countries to file a coordinated patent opposition on sofosbuvir with the European Patent Office ... Read more

March 23, 2017March 23, 2017

Gilead’s Harvoni Cured 97% of Hepatitis C Patients in Real-world Study

Hepatitis C, News

Prime Therapeutics recently announced that 97% of hepatitis C patients who were treated with Gilead’s Harvoni (ledipasvir/sofosbuvir) were cured of the virus in a new real-world study. The results obtained are similar to ... Read more

March 21, 2017March 21, 2017

HCV Gene Mutations Present New Challenges for Vaccine Development

Hepatitis C, News

The hepatitis C virus (HCV) is known to mutate to avoid recognition by antibodies, neutralizing molecules of the host’s immune system. Surprisingly, researchers found that these mutations can occur in ... Read more

March 14, 2017March 14, 2017

HCV Infection May Increase Risk of Cataracts, Study Finds

Hepatitis C, News

A recent study suggested a link between hepatitis C (HCV) infection and the development of cataracts. The study, “Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort ... Read more

March 9, 2017March 9, 2017

Baby Boomers at Risk of Hepatitis C Infection Aren’t Getting Tested, Despite Official Prodding

Hepatitis C, News

Despite official recommendations, most Americans born between 1945 and 1965 aren’t being tested for hepatitis C virus (HCV). That’s according to a new study, “Recent Hepatitis C Virus Testing Patterns Among Baby ... Read more

March 7, 2017March 7, 2017

Developing HCV Vaccine May Be Possible by Exposing Virus to Immune System Attack

Hepatitis C, News

Manipulating the major protein of the hepatitis C virus (HCV) allows the virus to be exposed in a way that the immune system can efficiently detect and attack it. This finding ... Read more

February 21, 2017February 21, 2017

‘Treat-All’ Medicaid Policy Improves Outcomes, Reduces Healthcare Costs in HCV

Hepatitis C, News

A restrictive Medicaid policy in many states limits hepatitis C virus (HCV) treatment to patients with severe disease, which leads to suboptimal treatment outcomes, high patient burden, and excessive costs. Now, ... Read more

January 31, 2017January 31, 2017

Hepatitis C Virus Associated with Multiple Cancers, Study Finds

Hepatitis C, News

The hepatitis C virus (HVC) had been linked previously to increased risk of a certain liver cancer and subtypes of non-Hodgkin lymphoma. Now a new study that examined more than ... Read more

January 26, 2017January 26, 2017

Marketing Application for HCV Treatment Candidate G/P Validated in Europe

Hepatitis C, News

AbbVie’s marketing authorization application (MAA) for its investigational drug glecaprevir/pibrentasvir (G/P), developed as a treatment for chronic hepatitis C virus (HCV) genotypes 1 to 6, has been validated by the European ... Read more